Yoram Azulai
Chief Executive Officer bij HBL - HADASIT BIO-HOLDINGS LTD
Profiel
Yoram Azulai is currently the Chief Executive Officer, CFO & Secretary at HBL- Hadasit Bio-Holdings Ltd.
He is also a Director at Zingenix Ltd.
and Tolaren Ltd.
Previously, he served as a Director at ProtAb Ltd.
Actieve functies van Yoram Azulai
| Bedrijven | Functie | Begin |
|---|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Chief Executive Officer | 31-03-2020 |
Zingenix Ltd.
 Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Director/Board Member | - |
| Tolaren Ltd. | Director/Board Member | - |
Eerdere bekende functies van Yoram Azulai
| Bedrijven | Functie | Einde |
|---|---|---|
ProtAb Ltd.
 ProtAb Ltd. Pharmaceuticals: MajorHealth Technology ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| Bedrijven in privébezit | 3 |
|---|---|
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology ProtAb Ltd. develops drug treatment for rheumatoid arthritis. It develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune inflammatory diseases. The company was Founded by Yaakov Naparstek in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
Zingenix Ltd.
Zingenix Ltd. BiotechnologyHealth Technology Zingenix Ltd. provides gene therapy for orphan disorders. The private company is based in Tel Aviv, Israel. | Health Technology |
| Tolaren Ltd. |
